Clinical Trial: A Study of Depemokimab in Participants of 6 to 11 Years of Age

U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07671001) titled 'A Study of Depemokimab in Participants of 6 to 11 Years of Age' on June 22.

Brief Summary: This study is aimed at assessing depemokimab as an add-on medicine for the treatment of asthma with type-2 inflammation in participants of 6 to 11 years of age. This study will test how the body processes depemokimab, how the drug works in the body, and its safety and tolerability.

Study Start Date: June 26

Study Type: INTERVENTIONAL

Condition: Asthma

Intervention: BIOLOGICAL: Depemokimab

Depemokimab will be administered.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: GlaxoSmithKline

Published by HT Digital Content Services with per...